In conclusion, our study demonstrates that CD3ζ plays a pivotal role in modulating immune signaling pathways that contribute to RGC degeneration and neuroprotection in glaucoma (Galindo-Romero et al., 2021; Shi et al., 2024). Here, CD247 is linked to glaucoma.